SOLICITATION NOTICE
B -- Pediatric Pulmonary Hypertension Actigraphy Endpoint Clinical Study - Notice of Intent
- Notice Date
- 6/9/2016
- Notice Type
- Presolicitation
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-SS-1168875
- Archive Date
- 7/23/2016
- Point of Contact
- Sean Wybenga, Phone: 240-402-7629
- E-Mail Address
-
sean.wybenga@fda.hhs.gov
(sean.wybenga@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Notice of Intent to Award a Sole Source Contract The Food and Drug Administration intends to make a sole source award to University of Colorado Denver (UCD) to conduct a pediatric pulmonary hypertension actigraphy endpoint clinical study and to report all actigraphy measurement and relevant clinical examination data to help addressing FDA's needs for scientific evidence on much needed efficacy endpoint development for pediatric pulmonary hypertension drug development in accordance with FAR 6.302-1. Only one responsible source and no other supplies or services will satisfy agency requirements.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-SS-1168875/listing.html)
- Record
- SN04144044-W 20160611/160609234324-d190b2019c7e29a0f04953a8401b42d2 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |